To investigate whether β-catenin destabilisation could decrease the expression of glycolytic enzymes induced by APC mutation in vivo, KYA1797K was applied to Apcmin/+ mice, which display increased tumour incidences in small intestines with Wnt/β-catenin signalling activation. The gene discussed is APC; the disease is neoplasm.